Refine by
Therapy Development Articles & Analysis: This-Year
15 articles found
They serve as essential signaling molecules that not only support the development of the nervous system during embryonic stages but also maintain neuronal health throughout an individual’s life. ...
The rat thymus, an essential organ in the immune system, plays a crucial role in the development and maturation of T-cells. Investigating the thymus of rats provides valuable insights into immunological processes and disease mechanisms. ...
Adenoviruses are a group of viruses that have gained significant attention in recent years, particularly in the fields of gene therapy, vaccine development, and cancer treatment. With their ability to deliver genetic material into cells effectively, adenoviruses serve as valuable vectors in various biomedical applications. ...
Alfa Cytology uses the latest biotechnological platforms to improve the development efficiency of one-stop solutions targeting FAP. Through the synergy of recombinant DNA technology and high-throughput screening researchers develop therapies specifically designed to match the distinctive traits of tumors expressing FAP. Alfa Cytology ...
Cancer treatment has witnessed transformative advancements over the past few decades, notably with the emergence of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This revolutionary therapy harnesses the body's immune system by genetically engineering T-cells to target and destroy cancer cells. ...
Furthermore, Alfa Cytology demonstrates its dedication to converting scientific discoveries into innovative solutions through its extensive development services on therapeutic antibody for cancer therapy. The firm develops monoclonal antibodies that target tumor-specific antigens through the services. ...
However, studies are exploring potential strategies to stimulate podocyte regeneration or to protect these cells from damage. Approaches such as gene therapy, stem cell treatment, and pharmacological interventions are being investigated as promising avenues for future treatments. ...
Human astrocytes-cerebellar (HA-c) represent a significant advancement in the field of neurobiology, particularly in understanding cerebral development, functionality, and pathology. Astrocytes, the star-shaped glial cells in the brain, play crucial roles in maintaining homeostasis, supporting neuronal function, and responding to injury. ...
This phenomenon offers a remarkable opportunity in cancer therapy. Tumors often exhibit mutations that can be exploited for targeted treatments. ...
These services encompass the design and optimization of molecules, antibody engineering techniques, and a variety of advanced antigen design strategies, all subjected to rigorous quality control to ensure compliance with the highest efficacy and safety standards. Furthermore, CAR T-cell therapy development services opened up new avenues for identifying ...
By creating cell lines with specific genes “knocked out,” scientists can investigate disease mechanisms, screen drug candidates, and develop gene therapies more effectively. This article explores the significance, methodologies, applications, and future prospects of custom knockout cell lines. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. ...
Moreover, hMSCs are being investigated for their role in delivering gene therapy. By genetically modifying these cells, researchers aim to enhance their therapeutic potential and target specific conditions more effectively. ...
By observing the effects of different compounds on nuclear receptors, scientists can gain insights into the mechanisms of disease and develop targeted therapies. Methodologies in Nuclear Receptor Screening Advancements in technology have revolutionized nuclear receptor screening methodologies. ...
Alfa Cytology introduces comprehensive small molecule PARPi development services for combating various diseases. Alfa Cytology, a developer of oncology innovation, has announced its latest venture small molecule Poly(ADP-ribose) polymerase inhibitor development services. ...